AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24748530 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot conditions
Number of subjects: 11
Study 24748530 — intervention group
Group type: EXPERIMENTAL
Intervention: Altitude
Number of subjects: 11
Study 23515373 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 154
Study 23515373 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 154
Study 23515373 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 154
Study 20567136 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program for balance and muscular strength (8 weeks)
Number of subjects: 33
Study 18383421 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention details not available)
Number of subjects: 3311
Study 16586336 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet group (Group A) - weight loss of approximately 5% through self-determined means
Number of subjects: 20
Study 16586336 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B) - maintained body weight
Number of subjects: 20
Study 12680735 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg pergolide (D1/D2 receptor agonist)
Number of subjects: 12
Study 12680735 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg bromocriptine (D2 receptor agonist)
Number of subjects: 12
Study 12680735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10385642 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (n = 14)
Number of subjects: 35
Study 10385642 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (n = 14)
Number of subjects: 35
Study 10385642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 35
Study 8971227 — intervention group
Group type: EXPERIMENTAL
Intervention: Spondylitis Functional Index (SFI) observed by physical therapists
Number of subjects: 30
Study 8971227 — intervention group
Group type: EXPERIMENTAL
Intervention: Spondylitis Functional Index (SFI) observed by observer 1
Number of subjects: 30
Study 8971227 — intervention group
Group type: EXPERIMENTAL
Intervention: Spondylitis Functional Index (SFI) observed by observer 2
Number of subjects: 30
Study 8971227 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-observer reliability of SFI
Number of subjects: 30
Study 1817471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervex sampler
Number of subjects: 240
Study 1817471 — intervention group
Group type: COMPARATOR
Intervention: Aylesbury spatula
Number of subjects: 240
Study 7042030 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection site in the arm
Number of subjects: 125
Study 7042030 — intervention group
Group type: COMPARATOR
Intervention: Injection site in the abdomen
Number of subjects: 125
Study 30887024 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA) with CT-derived fractional flow reserve (FFRCT)
Number of subjects: 20
Study 30887024 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA with FFRCT
Number of subjects: 20
Study 30518425 — intervention group
Group type: EXPERIMENTAL
Intervention: Audencel (dendritic cell-based immunotherapy)
Number of subjects: 0
Study 27052110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery followed by ingenol mebutate (CRY + IngMeb)
Number of subjects: 329
Study 27052110 — intervention group
Group type: COMPARATOR
Intervention: Cryosurgery followed by vehicle (CRY + vehicle)
Number of subjects: 329
Study 24333009 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg orally every day for 5 years
Number of subjects: 3864
Study 24333009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3864
Study 24333009 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 3864
Study 22665748 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular soft drink
Number of subjects: 20
Study 22665748 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy drink
Number of subjects: 20
Study 22665748 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet soft drink
Number of subjects: 20
Study 20363596 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation of 3.0 mmol of magnesium-chloride per kilogram of body weight in SES and SCS groups
Number of subjects: 40
Study 20363596 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation of 3.0 mmol of magnesium-chloride per kilogram of body weight in SES group
Number of subjects: 40
Study 20363596 — intervention group
Group type: COMPARATOR
Intervention: Control groups (SCS and UCS)
Number of subjects: 40
Study 18721344 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adapted mouthguard (MG2)
Number of subjects: 11
Study 18721344 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-fitted mouthguard (MG3)
Number of subjects: 11
Study 18721344 — intervention group
Group type: COMPARATOR
Intervention: No mouthguard (reference)
Number of subjects: 11
Study 16435702 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentive navigation technique
Number of subjects: 0
Study 16435702 — intervention group
Group type: COMPARATOR
Intervention: Free navigation techniques
Number of subjects: 0
Study 12591745 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracardiac echocardiography (ICE)
Number of subjects: 44
Study 12591745 — intervention group
Group type: COMPARATOR
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 44
Study 10475304 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (delayed recovery with propofol sedation for 2 hours)
Number of subjects: 30
Study 10475304 — intervention group
Group type: COMPARATOR
Intervention: Group I (early extubation)
Number of subjects: 30
Study 10475304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 8775244 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg mifepristone + 0.5 mg gemeprost
Number of subjects: 100
Study 8775244 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone + 1.0 mg gemeprost
Number of subjects: 100
Study 1615873 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide (300 mg) as a single oral loading dose
Number of subjects: 62
Study 1615873 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone (5 mg/kg as an intravenous bolus, followed by 1.8 g/day)
Number of subjects: 62
Study 1615873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 6528619 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of heparin
Number of subjects: 0
Study 6528619 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of heparin
Number of subjects: 0
Study 29130829 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy along with Kangaroo mother care (KMC)
Number of subjects: 70
Study 29130829 — intervention group
Group type: COMPARATOR
Intervention: Conventional phototherapy
Number of subjects: 70
Study 28591081 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance pattern
Number of subjects: 119
Study 28591081 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing pattern
Number of subjects: 119
Study 28591081 — intervention group
Group type: EXPERIMENTAL
Intervention: Overdoing pattern
Number of subjects: 119
Study 27359058 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg
Number of subjects: 221
Study 27359058 — intervention group
Group type: COMPARATOR
Intervention: Fulvestrant 250 mg
Number of subjects: 221
Study 27359058 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg (post-antiestrogen)
Number of subjects: 221
Study 27359058 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg (post-aromatase inhibitor)
Number of subjects: 221
Study 24678612 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito repellent and LLINs (Buzz-Off petroleum jelly, essential oil blend applied every evening)
Number of subjects: 6082
Study 24678612 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito repellent and LLINs
Number of subjects: 6082
Study 24678612 — intervention group
Group type: COMPARATOR
Intervention: LLINs alone
Number of subjects: 6082
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Stones intervention
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous rape perpetration
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: First-time rape perpetration
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-offending
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug use
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime partners
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical violence toward female partner
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure of rape perpetration at baseline
Number of subjects: 1147
Study 22675449 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to peer pressure
Number of subjects: 1147
Study 20173052 — intervention group
Group type: COMPARATOR
Intervention: Home monitoring (HM)
Number of subjects: 102
Study 20173052 — intervention group
Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 102
Study 18854763 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (EVR)
Number of subjects: 27
Study 18854763 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 27
Study 16446681 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus treatment (1,000 ml of water immediately before exercise)
Number of subjects: 6
Study 16446681 — intervention group
Group type: COMPARATOR
Intervention: Intermittent treatment (250 ml of water immediately before exercise and 250 ml at minutes 15, 30, and 45)
Number of subjects: 6
Study 11874392 — intervention group
Group type: EXPERIMENTAL
Intervention: Levormeloxifene 20-160 mg
Number of subjects: 104
Study 11874392 — intervention group
Group type: EXPERIMENTAL
Intervention: Levormeloxifene 2.5-320 mg (single doses)
Number of subjects: 104
Study 11874392 — intervention group
Group type: EXPERIMENTAL
Intervention: Levormeloxifene 160 mg (multiple dosing)
Number of subjects: 104
Study 11874392 — intervention group
Group type: EXPERIMENTAL
Intervention: Levormeloxifene
Number of subjects: 104
Study 11874392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 10509333 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser
Number of subjects: 15
Study 10509333 — intervention group
Group type: COMPARATOR
Intervention: Formocresol
Number of subjects: 15
Study 8039625 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous therapy with 6 MU of interferon alfa-2a, three times weekly for 9 months (group 1)
Number of subjects: 135
Study 8039625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent therapy with 6 MU of interferon alfa-2a for two 3-month cycles separated by a 6-month pause (group 2)
Number of subjects: 135
Study 8039625 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous therapy (group 1)
Number of subjects: 135
Study 8039625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent therapy (group 2)
Number of subjects: 135
Study 2905740 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 million units of interferon alpha three times a week for 12 weeks
Number of subjects: 67
Study 2905740 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 million units of interferon alpha three times a week for 12 weeks
Number of subjects: 67
Study 2905740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 2905740 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 million units of interferon alpha
Number of subjects: 67
Study 2905740 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 million units of interferon alpha
Number of subjects: 67
Study 31899948 — intervention group
Group type: EXPERIMENTAL
Intervention: Water containing 1.8375 × 10^10 cfu/l of probiotics for 8 weeks
Number of subjects: 48
Study 31899948 — intervention group
Group type: COMPARATOR
Intervention: Water without probiotics
Number of subjects: 48
Study 31899948 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics x week interaction
Number of subjects: 48
Study 31899948 — intervention group
Group type: EXPERIMENTAL
Intervention: Week of supplementation
Number of subjects: 48
Study 29703157 — intervention group
Group type: EXPERIMENTAL
Intervention: Low educational attainment (6 years or less)
Number of subjects: 1303
Study 29703157 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-collar job history
Number of subjects: 1303
Study 29703157 — intervention group
Group type: EXPERIMENTAL
Intervention: Low educational attainment (after adjustment for employment history)
Number of subjects: 1303
Study 29703157 — intervention group
Group type: EXPERIMENTAL
Intervention: Former habitual alcohol consumption, medical history of diabetes, Parkinson's disease, stroke, angina pectoris/cardiovascular disease
Number of subjects: 1303
Study 29703157 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational attainment
Number of subjects: 1303
Study 29703157 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational history
Number of subjects: 1303
Study 29703157 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 1303
Study 28558524 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM)
Number of subjects: 115
Study 28558524 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation (LKM)
Number of subjects: 115
Study 28558524 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation (active control group)
Number of subjects: 115
Study 25535142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban administration
Number of subjects: 104
Study 25535142 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 22339984 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help manual with standard care and treatment
Number of subjects: 56
Study 22339984 — intervention group
Group type: COMPARATOR
Intervention: Standard care and treatment
Number of subjects: 56
Study 21075855 — intervention group
Group type: EXPERIMENTAL
Intervention: Men (intervention group)
Number of subjects: 9362
Study 21075855 — intervention group
Group type: EXPERIMENTAL
Intervention: Women (intervention group)
Number of subjects: 9362
Study 17895883 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational, non‐competitive physical activity program (3 sessions of 90 minutes per week for 24 weeks)
Number of subjects: 1044
Study 17895883 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational, non‐competitive physical activity program
Number of subjects: 1044
Study 17895883 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1044
Study 15996602 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants
Number of subjects: 2648
Study 15996602 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2648
Study 12074792 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral prostatic nerve block prior to biopsy
Number of subjects: 108
Study 12074792 — intervention group
Group type: COMPARATOR
Intervention: No nerve block
Number of subjects: 108
Study 12074792 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia injection for repeat biopsy
Number of subjects: 108
Study 10342548 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular occlusion (early reduced light exposure)
Number of subjects: 0
Study 10342548 — intervention group
Group type: COMPARATOR
Intervention: No ocular occlusion (standard light exposure)
Number of subjects: 0
Study 8869329 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 89
Study 8869329 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy and S-shaped gastric substitute
Number of subjects: 89
Study 8869329 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal gastrectomy
Number of subjects: 89
Study 8869329 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric pouch or subtotal gastrectomy
Number of subjects: 89
Study 8869329 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric reservoir (total gastrectomy with S-shaped substitute)
Number of subjects: 89
Study 1565550 — intervention group
Group type: EXPERIMENTAL
Intervention: Myringotomy with tube insertion
Number of subjects: 220
Study 1565550 — intervention group
Group type: EXPERIMENTAL
Intervention: Myringotomy alone
Number of subjects: 220
Study 1565550 — intervention group
Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 220
Study 6338890 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-admission scheme for myocardial infarction
Number of subjects: 511
Study 30718450 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the associative-limbic subthalamic nucleus (STN)
Number of subjects: 10
Study 30718450 — intervention group
Group type: COMPARATOR
Intervention: Off stimulation (control condition)
Number of subjects: 10
Study 27349461 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness (measured using the Five Facet Mindfulness Questionnaire)
Number of subjects: 80
Study 27349461 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness facets (Describing, Acting-with-Awareness, Non-judging)
Number of subjects: 80
Study 26954319 — intervention group
Group type: EXPERIMENTAL
Intervention: DFD‐01 (0.05% betamethasone dipropionate in emollient spray)
Number of subjects: 538
Study 26954319 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 538
Study 25136645 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME) for 3 months, including 8 weeks of education and 4 weeks of practice
Number of subjects: 76
Study 25136645 — intervention group
Group type: COMPARATOR
Intervention: Standard advice on medical nutrition therapy (Control)
Number of subjects: 76
Study 22955355 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus salivarius LS01 and Bifidobacterium breve BR03)
Number of subjects: 48
Study 22955355 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 48
Study 20608142 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml 2% lidocaine
Number of subjects: 220
Study 20608142 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml 2% mepivacaine
Number of subjects: 220
Study 20608142 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 220
Study 17470962 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuclopenthixol (discontinued after 6 weeks)
Number of subjects: 39
Study 17470962 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=20)
Number of subjects: 39
Study 15482535 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine 100 mg/day for up to 5 years
Number of subjects: 58
Study 12133355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) with 5 min of ischemia and 5 min of reperfusion
Number of subjects: 29
Study 12133355 — intervention group
Group type: COMPARATOR
Intervention: Control group: simple hepatic blood inflow occlusion (HBIO)
Number of subjects: 29
Study 9661540 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (30 mg/kg during sternotomy and 30 mg/kg during initiation of cardiopulmonary bypass)
Number of subjects: 60
Study 9661540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 9661540 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 60
Study 7620696 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (20 mg daily)
Number of subjects: 16
Study 7620696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 7620696 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 16
Study 2123367 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (100 mg, 6 weeks)
Number of subjects: 72
Study 2123367 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (33 mg, 6 weeks)
Number of subjects: 72
Study 2123367 — intervention group
Group type: COMPARATOR
Intervention: Placebo (6 weeks)
Number of subjects: 72
Study 2123367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 2123367 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 72
Study 2123367 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (52-week assessment)
Number of subjects: 72
Study 6274592 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid sutures (PGA)
Number of subjects: 0
Study 6274592 — intervention group
Group type: COMPARATOR
Intervention: Polyester sutures
Number of subjects: 0
Study 31390617 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 62
Study 31390617 — intervention group
Group type: COMPARATOR
Intervention: Active control intervention (progressive muscle relaxation and psychoeducation)
Number of subjects: 62
Study 31002554 — intervention group
Group type: EXPERIMENTAL
Intervention: Local warming at 42ºC for 10 minutes
Number of subjects: 55
Study 28933799 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily
Number of subjects: 700
Study 28933799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 700
Study 26267747 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal prostaglandin E1 (lipo‐PGE1) 20 μg/day diluted in 10 ml of normal saline, administered intravenously over 5 min starting 3 days before PCI and continuing for 4 days after PCI
Number of subjects: 219
Study 26267747 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal prostaglandin E1 (lipo‐PGE1)
Number of subjects: 219
Study 26267747 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal saline 10 ml administered intravenously)
Number of subjects: 219
Study 25055027 — intervention group
Group type: EXPERIMENTAL
Intervention: NAP SACC program (treatment group)
Number of subjects: 209
Study 25055027 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 209
Study 25055027 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 209